WisdomTree BioRevolution Fund (WDNA)

Assets	$2.47M
Expense Ratio	0.45%
PE Ratio	17.02
Shares Out	150,000
Dividend (ttm)	$0.14
Dividend Yield	0.83%
Ex-Dividend Date	Dec 22, 2023
Payout Ratio	14.02%
1-Year Return	-11.51%

Volume	145
Open	16.39
Previous Close	16.45
Day's Range	16.18 - 16.45
52-Week Low	13.37
52-Week High	18.48
Beta	1.25
Holdings	91
Inception Date	Jun 3, 2021

About WDNA

Fund Home Page

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is issued by WisdomTree.

• Asset Class: Equity
• Category: Health
• Stock Exchange: BATS
• Ticker Symbol: WDNA
• ETF Provider: WisdomTree
• Index Tracked: WisdomTree BioRevolution Index

Top 10 Holdings

25.12% of assets

Name	Symbol	Weight
Twist Bioscience Corporation	TWST	4.16%
Blueprint Medicines Corporation	BPMC	2.82%
Novonesis AS Class B	NSIS B.CO	2.75%
Geron Corporation	GERN	2.59%
Agios Pharmaceuticals, Inc.	AGIO	2.41%
Natera, Inc.	NTRA	2.36%
Eli Lilly and Company	LLY	2.31%
Vericel Corporation	VCEL	2.13%
Fate Therapeutics, Inc.	FATE	1.80%
Sarepta Therapeutics, Inc.	SRPT	1.77%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 22, 2023	$0.135	Dec 28, 2023
Dec 23, 2022	$0.06526	Dec 29, 2022
Dec 27, 2021	$0.02458	Dec 30, 2021